One Range for Every Market, or Local Scents? Trade-offs for a Pharmacy Line
Most pharmacy groups do not decide between one global range and several local ones. The decision gets made for them, quietly, as a second market asks for a tweak, a distributor asks for a warmer variant and a local buyer asks for a different name on the pack. Two seasons later the range has six variations, three of which nobody planned. Looking at the trade-offs honestly before that happens is cheaper than unpicking the result, and the honest answer is that a single range carries further than most buyers expect.
Key takeaways
- Localising a fragrance range multiplies development, testing, packaging and inventory work, so the case for it has to be commercial rather than stylistic.
- A single range travels further when the scent is simple, the format is familiar and the name does not depend on a local reference to be understood.
- Regulatory differences are unavoidable per market, but they usually change labels and documentation rather than the scent itself.
- Partial localisation, one scent with market-specific packaging or copy, is often the best compromise because it protects the formula and the tooling.
- Whichever route you choose, the range architecture should be written down, including what may vary and what may not.
Range architecture is an unglamorous subject with a direct effect on margin. Every additional scent variation carries its own development cost, its own sample rounds, its own stability work, its own artwork, its own minimum order quantities and its own shelf space. Those costs are easy to see when they are planned and almost invisible when they accumulate one request at a time.
This is written for the person who owns the category rather than the creative direction: a procurement or category manager inside a pharmacy or drugstore group, deciding how far one range can stretch across markets without losing either coherence or sales.
How ranges drift into local variants
Localisation rarely arrives as a strategy. It arrives as an accommodation: a market manager wants a version that suits their shoppers, a distributor reports that a competitor's scent is selling better, and an agreement is reached before anyone costs the extra variation. None of these requests is unreasonable on its own. Together they produce a range that no longer has a recognisable core, which is precisely what own-label pharmacy ranges rely on.
The counterweight is to define the core before the requests start. A stated house direction, a stated format family and a stated rule about what can be changed without a new development round give the commercial team something to negotiate with, and they give the manufacturer a stable target.
It also helps to know how much common ground exists across export markets in practice. Manufacturers that serve many countries publish their category coverage and service model, and looking at the Xuelei website makes the point quickly: a single development and production platform can cover fragrances, home products and personal care for many markets without rebuilding the range for each one.
Where the two routes actually differ
| Decision | Localise per market | One range for every market | Where it usually lands |
|---|---|---|---|
| Development cost | A new brief, a new sample round and a new approval for each market | One development cycle, reused across markets | One core development with a small budget reserved for justified variants |
| Testing | Stability and compatibility work repeated for each variant and pack | Testing done once per format, then repeated only when the pack changes | One test set per format, with the pack as the variable that triggers retesting |
| Packaging and tooling | Separate artwork, separate print runs and smaller batches per market | One artwork system, larger print runs and better unit economics | Shared tooling with market-specific copy on a common structure |
| Inventory | More SKUs to forecast, and more slow-moving stock when a market guesses wrong | Fewer SKUs, simpler forecasting and faster replenishment | A short core range with a limited local add-on, reviewed each season |
| Brand coherence | Each market can read as a different brand | The range accumulates recognition across markets | One recognisable core, with variation confined to naming and copy |
| Shopper fit | Better fit to local habits, occasions and price expectations | Occasionally a scent that is merely acceptable everywhere | Local habit handled through format and price, not through the scent |
The pattern in the right-hand column is not a compromise born of laziness. It is what most small and mid-sized pharmacy ranges converge on once they have costed both routes.
The three trade-offs that decide it
The first is complexity cost, and it is larger than most category managers expect. Each additional variant carries a minimum order quantity for the fragrance, for the bottle and for the carton, and those minimums do not shrink just because the market is small. A variant that sells acceptably can still destroy its own margin through inventory and artwork alone.
The second is shopper fit. There is real evidence that scent preferences vary with climate, habit and occasion, and trend research tracking consumer behaviour across markets is a reasonable starting point for judging how much variation is worth paying for [1]. The caution is that broad trend work describes directions rather than sales, so it should inform what you test rather than what you launch.
The third is regulatory. Rules that affect fragrance and personal care products differ by market, and while the differences often land on labelling, documentation and permitted claims, they can also restrict materials in a way that changes the formula [2]. That is the one area where local variation is not optional, and it should be identified market by market before any range decision is taken.
Formulation practice is a fourth consideration worth understanding without over-reading. Reviews of how personal care products are formulated and tested show how much of a product's behaviour comes from its base and its pack rather than from the fragrance alone, which is useful when you are trying to decide whether a market really needs a different scent or simply a different format [3].
Partial localisation usually wins
The most common resolution is a single core scent with market-specific packaging, naming or copy, and a format that suits local shopping habits. This keeps the formula, the development work and the tooling shared while giving the market something that feels local. It also keeps the door open: if a market genuinely needs a second direction, that decision can be made with sales evidence rather than with a hunch.
Working through private label fragrance production makes this kind of architecture easier to hold, because the formula and the pack are treated as separate decisions. Buyers who want the scent fixed and the presentation flexible should say so explicitly in the brief, since the default assumption on the factory side is often the opposite.
Watch how comparable brands have handled it
The global market has spent the last decade absorbing fragrance brands from markets that were once treated as suppliers rather than competitors, and that shift has made range architecture a live question for Chinese and other Asian brands as well Chinese perfume brands. The lesson for a pharmacy group is not that one model wins, but that brands with a clear core travel further than brands assembled market by market.
Look at how a competitor's range is structured before you look at its scents: how many directions, how many formats, how many packs. That single view usually explains more about the commercial logic than the fragrance descriptions do.
Decide the rule, not the individual variants. Write down what is fixed across markets, what may vary, and who has the authority to approve a new variation. A rule agreed in a calm quarter is worth more than a debate held during a launch.
Sources
- Mintel Press Centre —— Mintel's press releases on consumer and beauty market research, including fragrance and personal care trend reporting.
- European Commission: Cosmetics in the EU —— The European Commission's overview of EU cosmetics rules, including the responsible person, product information file and safety report requirements.
- Cosmetics & Toiletries —— A technical magazine for cosmetic formulators, covering ingredients, formulation science and testing methods.
Frequently asked questions
Is it cheaper to localise or to standardise a fragrance range?
Standardising is almost always cheaper, because development, testing, tooling and inventory are shared. Localising is justified when a market's sales evidence shows that the shared version underperforms enough to pay back the extra cost.
Can one scent really work across very different markets?
Often yes, particularly for clean, simple, easily described directions in familiar formats. Scent that depends on local memory or a specific cultural reference is harder to transfer.
How many scent variants should a small pharmacy range carry?
Fewer than most buyers expect. Two or three directions across the formats you actually stock is enough for a first range, and it keeps minimum order quantities and shelf complexity manageable.
Does regulation force different formulas in different markets?
It can, when a material is restricted or a claim is not permitted. More often the difference lands on labels, documentation and claim wording, which is a much cheaper kind of variation to manage.
What should stay fixed when localising?
The core direction, the concentration and the quality level. If those move, you are developing a different product rather than presenting the same one differently.
Have a brief worth directing?
We take on a handful of campaigns each quarter. Tell us about the project — we'll respond within two business days.